Distinct epicardial gene regulatory programs drive development and regeneration of the zebrafish heart
Journal article
WEINBERGER M. et al, (2024), Developmental Cell
Distinct epicardial gene regulatory programs drive development and regeneration of the zebrafish heart
Journal article
WEINBERGER M. et al, (2024), Developmental Cell
Cellular crosstalk to regenerate the injured heart
Journal article
Riley PR., (2024), Nature Cardiovascular Research
Striatin plays a major role in angiotensin II-induced cardiomyocyte and cardiac hypertrophy in micein vivo
Preprint
Cull JJ. et al, (2023)
Animal models to study cardiac regeneration.
Journal article
Weinberger M. and Riley PR., (2023), Nat Rev Cardiol
Animal models to study cardiac regeneration
Journal article
WEINBERGER M. and RILEY P., (2023), Nature Reviews Cardiology
Erratum to ‘Defining Commotio Cordis’: The American Journal of Cardiology Volume 124, Issue 10, 15 November 2019, Pages 1649-1650 (The American Journal of Cardiology (2019) 124(10) (1649–1650), (S0002914919309415), (10.1016/j.amjcard.2019.08.006))
Journal article
Maron BJ. et al, (2023), American Journal of Cardiology, 193
Abstract P3113: RAF 'Paradox Breaker' Inhibitor, PLX8394, Enhances Inflammation And Apoptosis In Murine Hypertension In Vivo
Conference paper
Cooper S. et al, (2023)
Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in mice.
Journal article
Alharbi HO. et al, (2022), Clin Sci (Lond), 136, 1661 - 1681
PKN2 deficiency leads both to prenatal 'congenital' cardiomyopathy and defective angiotensin II stress responses.
Journal article
Marshall JJT. et al, (2022), Biochem J, 479, 1467 - 1486
Of Mouse and Man: Cross-Species Characterization of Hypertensive Cardiac Remodeling.
Journal article
Cooper STE. et al, (2022), Int J Mol Sci, 23
BS8 RAF ‘paradox breaker’ PLX8394 activates ERK1/2 VIA craf, with no effect on angii-induced cardiac remodelling in mice
Conference paper
Cooper S. et al, (2022), Basic science
Immune cells in cardiac repair and regeneration.
Journal article
Simões FC. and Riley PR., (2022), Development, 149
Characterisation of hypertensive heart disease: pathological insights from a sudden cardiac death cohort to inform clinical practice.
Journal article
Westaby JD. et al, (2022), J Hum Hypertens, 36, 246 - 253
Mapping the developing human cardiac endothelium at single cell resolution identifies MECOM as a regulator of arteriovenous gene expression.
Journal article
McCracken IR. et al, (2022), Cardiovasc Res
Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo.
Journal article
Clerk A. et al, (2022), Biochem J, 479, 401 - 424
Rapid neutrophil mobilisation by VCAM-1+ endothelial extracellular vesicles.
Journal article
Akbar N. et al, (2022), Cardiovasc Res
Protocols for Investigating the Epithelial Properties of Cardiac Progenitor Cells in the Mouse Embryo.
Chapter
Cortes C. et al, (2022), 2438, 231 - 250
Quantitative Three-Dimensional Analysis of the Lymphatic Vasculature in the Postnatal Mouse Heart.
Journal article
Klaourakis K. et al, (2022), Methods Mol Biol, 2441, 171 - 181
The anti-cancer drug dabrafenib is not cardiotoxic and inhibits cardiac remodelling and fibrosis in a murine model of hypertension.
Journal article
Meijles DN. et al, (2021), Clin Sci (Lond), 135, 1631 - 1647